HomeCompareCATI vs GBDC

CATI vs GBDC: Dividend Comparison 2026

CATI yields 666.67% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CATI wins by $608094.88M in total portfolio value
10 years
CATI
CATI
● Live price
666.67%
Share price
$0.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$608115.66M
Annual income
$469,561,018,816.25
Full CATI calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — CATI vs GBDC

📍 CATI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCATIGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CATI + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CATI pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CATI
Annual income on $10K today (after 15% tax)
$56,666.67/yr
After 10yr DRIP, annual income (after tax)
$399,126,865,993.81/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, CATI beats the other by $399,112,935,119.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CATI + GBDC for your $10,000?

CATI: 50%GBDC: 50%
100% GBDC50/50100% CATI
Portfolio after 10yr
$304068.22M
Annual income
$234,788,704,039.82/yr
Blended yield
77.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

CATI
No analyst data
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CATI buys
0
GBDC buys
2
PoliticianChamberTickerTypeAmountDate
David P. Joyce🏢 House$GBDC▼ Sell$1,001 - $15,0002023-06-30
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002023-06-19
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-14
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-12
Teresa Leger Fernandez🏢 House$GBDC▼ Sell$15,001 - $50,0002021-01-20
David P. Joyce🏢 House$GBDC▲ Buy$1,001 - $15,0002020-02-25
David P. Joyce🏢 House$GBDC▲ Buy$15,001 - $50,0002019-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCATIGBDC
Forward yield666.67%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$608115.66M$20.78M
Annual income after 10y$469,561,018,816.25$16,389,263.41
Total dividends collected$596792.85M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: CATI vs GBDC ($10,000, DRIP)

YearCATI PortfolioCATI Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$77,367$66,666.67$12,490$1,790.28+$64.9KCATI
2$564,818$482,035.31$16,522$3,157.73+$548.3KCATI
3$3,893,246$3,288,890.67$23,578$5,898.68+$3.87MCATI
4$25,352,760$21,186,987.16$37,115$11,886.75+$25.32MCATI
5$156,070,781$128,943,327.59$66,136$26,423.57+$156.00MCATI
6$908,837,800$741,842,064.29$137,257$66,491.44+$908.70MCATI
7$5,009,769,782$4,037,313,336.56$341,734$194,868.54+$5009.43MCATI
8$26,159,339,258$20,798,885,591.56$1,050,788$685,133.02+$26158.29MCATI
9$129,490,317,125$101,499,824,118.87$4,099,314$2,974,971.01+$129486.22MCATI
10$608,115,658,140$469,561,018,816.25$20,775,530$16,389,263.41+$608094.88MCATI

CATI vs GBDC: Complete Analysis 2026

CATIStock

Clone Algo Technologies Inc., a technology company, develops algorithms and risk management systems based on artificial intelligence. Its products include Clone Algo, a social investment network app that enables users to clone trades from master accounts to users own account with connected brokers, banks, and hedge funds using algorithms, and advanced cloning and non-predictive timing technology; HomeAway, a hotel booking and management system for booking discounted hotel room rates; and AlgoTrust, a mobile banking system for do it yourself banking. The company was formerly known as Travelsafe, Inc. and changed its name to Clone Algo Technologies Inc. in September 2014. Clone Algo Technologies Inc. was founded in 2013 and is based in Chapel Hill, North Carolina.

Full CATI Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this CATI vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CATI vs SCHDCATI vs JEPICATI vs OCATI vs KOCATI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.